Publication list - Publika - Scientific publications from Oslo University Hospital

Publications by Torbjørn Leivestad

183 publications found

Original articles

Jakobsen A, Leivestad T, Pfeffer P, Thorsby E (2019)
Scandiatransplant 50 years- a successful Nordic collaboration on organ transplantation
Tidsskr. Nor. Laegeforen., 139 (8), 744-748

Jakobsen A, Leivestad T, Pfeffer P, Thorsby E (2019)
[Scandiatransplant’s 50th jubilee – a successful Nordic collaboration on organ transplantation]
Tidsskr Nor Laegeforen, 139 (8)
DOI 10.4045/tidsskr.19.0043, PubMed 31062547

Rizvi SMH, Aagnes B, Holdaas H, Gude E, Boberg KM, Bjørtuft Ø, Helsing P, Leivestad T, Møller B, Gjersvik P (2017)
Long-term Change in the Risk of Skin Cancer After Organ Transplantation: A Population-Based Nationwide Cohort Study
JAMA Dermatol, 153 (12), 1270-1277
DOI 10.1001/jamadermatol.2017.2984, PubMed 29049612

Gagnum V, Saeed M, Stene LC, Leivestad T, Joner G, Skrivarhaug T (2017)
Low Incidence of End-Stage Renal Disease in Childhood-Onset Type 1 Diabetes Followed for Up to 42 Years
Diabetes Care, 41 (3), 420-425
DOI 10.2337/dc17-0906, PubMed 29025877

Dahle DO, Grotmol T, Leivestad T, Hartmann A, Midtvedt K, Reisæter AV, Mjøen G, Pihlstrøm HK, Næss H, Holdaas H (2017)
Association Between Pretransplant Cancer and Survival in Kidney Transplant Recipients
Transplantation, 101 (10), 2599-2605
DOI 10.1097/TP.0000000000001659, PubMed 28207636

Lindahl JP, Massey RJ, Hartmann A, Aakhus S, Endresen K, Günther A, Midtvedt K, Holdaas H, Leivestad T, Horneland R, Øyen O, Jenssen T (2017)
Cardiac Assessment of Patients With Type 1 Diabetes Median 10 Years After Successful Simultaneous Pancreas and Kidney Transplantation Compared With Living Donor Kidney Transplantation
Transplantation, 101 (6), 1261-1267
DOI 10.1097/TP.0000000000001274, PubMed 27467687

Heldal K, Hartmann A, Lønning K, Leivestad T, Reisæter AV, Line PD, Holdaas H, Midtvedt K (2017)
Should patients older than 65 years be offered a second kidney transplant?
BMC Nephrol, 18 (1), 13
DOI 10.1186/s12882-016-0426-0, PubMed 28077080

Lønning K, Midtvedt K, Leivestad T, Reisæter AV, Line PD, Hartmann A, Heldal K (2016)
Are Octogenarians With End-Stage Renal Disease Candidates for Renal Transplantation?
Transplantation, 100 (12), 2705-2709
DOI 10.1097/TP.0000000000001363, PubMed 27861296

Gagnum V, Stene LC, Leivestad T, Joner G, Skrivarhaug T (2016)
Long-term Mortality and End-Stage Renal Disease in a Type 1 Diabetes Population Diagnosed at Age 15-29 Years in Norway
Diabetes Care, 40 (1), 38-45
DOI 10.2337/dc16-1213, PubMed 27797927

Lindahl JP, Hartmann A, Aakhus S, Endresen K, Midtvedt K, Holdaas H, Leivestad T, Horneland R, Øyen O, Jenssen T (2015)
Long-term cardiovascular outcomes in type 1 diabetic patients after simultaneous pancreas and kidney transplantation compared with living donor kidney transplantation
Diabetologia, 59 (4), 844-52
DOI 10.1007/s00125-015-3853-8, PubMed 26713324

Waldum-Grevbo B, Leivestad T, Reisæter AV, Os I (2015)
Impact of initial dialysis modality on mortality: a propensity-matched study
BMC Nephrol, 16, 179
DOI 10.1186/s12882-015-0175-5, PubMed 26519164

Pippias M, Jager KJ, Kramer A, Leivestad T, Sánchez MB, Caskey FJ, Collart F, Couchoud C, Dekker FW, Finne P, Fouque D, Heaf JG, Hemmelder MH, Kramar R, De Meester J, Noordzij M, Palsson R, Pascual J, Zurriaga O, Wanner C, Stel VS (2015)
The changing trends and outcomes in renal replacement therapy: data from the ERA-EDTA Registry
Nephrol Dial Transplant, 31 (5), 831-41
DOI 10.1093/ndt/gfv327, PubMed 26361801

Dahle DO, Eide IA, Åsberg A, Leivestad T, Holdaas H, Jenssen TG, Fagerland MW, Pihlstrøm H, Mjøen G, Hartmann A (2015)
Aortic Stiffness in a Mortality Risk Calculator for Kidney Transplant Recipients
Transplantation, 99 (8), 1730-7
DOI 10.1097/TP.0000000000000660, PubMed 25757216

Morken NH, Diaz-Garcia C, Reisaeter AV, Foss A, Leivestad T, Geiran O, Hervás D, Brännström M (2015)
Obstetric and neonatal outcome of pregnancies fathered by males on immunosuppression after solid organ transplantation
Am J Transplant, 15 (6), 1666-73
DOI 10.1111/ajt.13159, PubMed 25868657

Sandvik LF, Skarstein K, Krynitz B, Volchenkov R, Sviland L, Leivestad T, Jonsson R, Appel S (2015)
Peritumoral dermis of squamous cell carcinomas in renal transplant recipients contains less CD11c+ myeloid dendritic cells and FoxP3+ T cells compared to immunocompetent controls
J Eur Acad Dermatol Venereol, 29 (11), 2128-35
DOI 10.1111/jdv.13151, PubMed 25845701

Pippias M, Stel VS, Abad Diez JM, Afentakis N, Herrero-Calvo JA, Arias M, Tomilina N, Bouzas Caamaño E, Buturovic-Ponikvar J, Čala S, Caskey FJ, Castro de la Nuez P, Cernevskis H, Collart F, Alonso de la Torre R, García Bazaga Mde L, De Meester J, Díaz JM, Djukanovic L, Ferrer Alamar M, Finne P, Garneata L, Golan E, González Fernández R, Gutiérrez Avila G et al. (2015)
Renal replacement therapy in Europe: a summary of the 2012 ERA-EDTA Registry Annual Report
Clin Kidney J, 8 (3), 248-61
DOI 10.1093/ckj/sfv014, PubMed 26034584

Norum J, Leivestad T, Eriksen BO, Skår S, Fagerheim A, Reisæter AV (2015)
Regional differences in renal replacement therapy in northern Norway 2000-2012
Int J Circumpolar Health, 74, 24298
DOI 10.3402/ijch.v74.24298, PubMed 25672881

Vogelzang JL, van Stralen KJ, Noordzij M, Diez JA, Carrero JJ, Couchoud C, Dekker FW, Finne P, Fouque D, Heaf JG, Hoitsma A, Leivestad T, de Meester J, Metcalfe W, Palsson R, Postorino M, Ravani P, Vanholder R, Wallner M, Wanner C, Groothoff JW, Jager KJ (2015)
Mortality from infections and malignancies in patients treated with renal replacement therapy: data from the ERA-EDTA registry
Nephrol Dial Transplant, 30 (6), 1028-37
DOI 10.1093/ndt/gfv007, PubMed 25637641

Noordzij M, Jager KJ, van der Veer SN, Kramar R, Collart F, Heaf JG, Stojceva-Taneva O, Leivestad T, Buturovic-Ponikvar J, Benítez Sánchez M, Moreso F, Prütz KG, Severn A, Wanner C, Vanholder R, Ravani P (2014)
Use of vascular access for haemodialysis in Europe: a report from the ERA-EDTA Registry
Nephrol Dial Transplant, 29 (10), 1956-64
DOI 10.1093/ndt/gfu253, PubMed 25061126

Bleskestad IH, Bergrem H, Leivestad T, Hartmann A, Gøransson LG (2014)
Parathyroid hormone and clinical outcome in kidney transplant patients with optimal transplant function
Clin Transplant, 28 (4), 479-86
DOI 10.1111/ctr.12341, PubMed 25649861

Noordzij M, Kramer A, Abad Diez JM, Alonso de la Torre R, Arcos Fuster E, Bikbov BT, Bonthuis M, Bouzas Caamaño E, Čala S, Caskey FJ, Castro de la Nuez P, Cernevskis H, Collart F, Díaz Tejeiro R, Djukanovic L, Ferrer-Alamar M, Finne P, García Bazaga Mde L, Garneata L, Golan E, Gonzalez Fernández R, Heaf JG, Hoitsma A, Ioannidis GA, Kolesnyk M et al. (2014)
Renal replacement therapy in Europe: a summary of the 2011 ERA-EDTA Registry Annual Report
Clin Kidney J, 7 (2), 227-38
DOI 10.1093/ckj/sfu007, PubMed 25852881

Sandvik LF, Skarstein K, Sviland L, Svarstad E, Nilsen AE, Leivestad T, Jonsson R, Appel S (2014)
CD11c(+) dendritic cells rather than Langerhans cells are reduced in normal skin of immunosuppressed renal transplant recipients
Acta Derm Venereol, 94 (2), 173-8
DOI 10.2340/00015555-1679, PubMed 23995623

Dahle DO, Jenssen T, Holdaas H, Leivestad T, Vårdal M, Mjøen G, Reisaeter AV, Toft I, Hartmann A (2013)
Uric acid has a J-shaped association with cardiovascular and all-cause mortality in kidney transplant recipients
Clin Transplant, 28 (1), 134-40
DOI 10.1111/ctr.12290, PubMed 24372653

Smedbråten YV, Sagedal S, Leivestad T, Mjøen G, Osnes K, Rollag H, Reisaeter AV, Foss A, Os I, Hartmann A (2013)
The impact of early cytomegalovirus infection after kidney transplantation on long-term graft and patient survival
Clin Transplant, 28 (1), 120-6
DOI 10.1111/ctr.12288, PubMed 24351078

Mjøen G, Hallan S, Hartmann A, Foss A, Midtvedt K, Øyen O, Reisæter A, Pfeffer P, Jenssen T, Leivestad T, Line PD, Øvrehus M, Dale DO, Pihlstrøm H, Holme I, Dekker FW, Holdaas H (2013)
Long-term risks for kidney donors
Kidney Int, 86 (1), 162-7
DOI 10.1038/ki.2013.460, PubMed 24284516

Andresen PA, Nymoen DA, Kjærheim K, Leivestad T, Helsing P (2013)
Susceptibility to Cutaneous Squamous Cell Carcinoma in Renal Transplant Recipients Associates with Genes Regulating Melanogenesis Independent of their Role in Pigmentation
Biomark Cancer, 5, 41-7
DOI 10.4137/BIC.S12754, PubMed 24179397

Lægreid IK, Aasarød K, Bye A, Leivestad T, Jordhøy M (2013)
The impact of nutritional status, physical function, comorbidity and early versus late start in dialysis on quality of life in older dialysis patients
Ren Fail, 36 (1), 9-16
DOI 10.3109/0886022X.2013.830206, PubMed 24028283

Dörje C, Midtvedt K, Holdaas H, Naper C, Strøm EH, Øyen O, Leivestad T, Aronsen T, Jenssen T, Flaa-Johnsen L, Lindahl JP, Hartmann A, Reisæter AV (2013)
Early versus late acute antibody-mediated rejection in renal transplant recipients
Transplantation, 96 (1), 79-84
DOI 10.1097/TP.0b013e31829434d4, PubMed 23632391

Heldal K, Thorarinsdottir S, Hartmann A, Leivestad T, Reisæter AV, Foss AE, Midtvedt K (2013)
Induction with interleukin-2 antagonist for transplantation of kidneys from older deceased donors: an observational study
Transplant Res, 2 (1), 11
DOI 10.1186/2047-1440-2-11, PubMed 23799993

Schroijen MA, van de Luijtgaarden MW, Noordzij M, Ravani P, Jarraya F, Collart F, Prütz KG, Fogarty DG, Leivestad T, Prischl FC, Wanner C, Dekker FW, Jager KJ, Dekkers OM (2013)
Survival in dialysis patients is different between patients with diabetes as primary renal disease and patients with diabetes as a co-morbid condition
Diabetologia, 56 (9), 1949-57
DOI 10.1007/s00125-013-2966-1, PubMed 23771173

Lindahl JP, Hartmann A, Horneland R, Holdaas H, Reisæter AV, Midtvedt K, Leivestad T, Oyen O, Jenssen T (2013)
Improved patient survival with simultaneous pancreas and kidney transplantation in recipients with diabetic end-stage renal disease
Diabetologia, 56 (6), 1364-71
DOI 10.1007/s00125-013-2888-y, PubMed 23549518

Dahle DO, Midtvedt K, Hartmann A, Jenssen T, Holdaas H, Mjøen G, Leivestad T, Asberg A (2013)
Endothelial dysfunction is associated with graft loss in renal transplant recipients
Transplantation, 95 (5), 733-9
DOI 10.1097/TP.0b013e31827d6312, PubMed 23364481

Kramer A, Stel VS, Abad Diez JM, Alonso de la Torre R, Bouzas Caamaño E, Čala S, Cao Baduell H, Castro de la Nuez P, Cernevskis H, Collart F, Couchoud C, de Meester J, Djukanovic L, Ferrer-Alamar M, Finne P, Fogarty D, de Los Ángeles García Bazaga M, Garneata L, Golan E, Gonzalez Fernández R, Heaf JG, Hoitsma A, Ioannidis GA, Kolesnyk M, Kramar R et al. (2013)
Renal replacement therapy in Europe-a summary of the 2010 ERA-EDTA Registry Annual Report
Clin Kidney J, 6 (1), 105-115
DOI 10.1093/ckj/sfs164, PubMed 27818766

Åsberg A, Apeland T, Reisaeter AV, Foss A, Leivestad T, Heldal K, Thorud LO, Eriksen BO, Hartmann A, NILS Study Group (2013)
Long-term outcomes after cyclosporine or mycophenolate withdrawal in kidney transplantation - results from an aborted trial
Clin Transplant, 27 (2), E151-6
DOI 10.1111/ctr.12076, PubMed 23351013

Ocak G, van Stralen KJ, Rosendaal FR, Verduijn M, Ravani P, Palsson R, Leivestad T, Hoitsma AJ, Ferrer-Alamar M, Finne P, De Meester J, Wanner C, Dekker FW, Jager KJ (2012)
Mortality due to pulmonary embolism, myocardial infarction, and stroke among incident dialysis patients
J Thromb Haemost, 10 (12), 2484-93
DOI 10.1111/j.1538-7836.2012.04921.x, PubMed 22970891

Valderhaug TG, Hjelmesæth J, Jenssen T, Røislien J, Leivestad T, Hartmann A (2012)
Early posttransplantation hyperglycemia in kidney transplant recipients is associated with overall long-term graft losses
Transplantation, 94 (7), 714-20
DOI 10.1097/TP.0b013e31825f4434, PubMed 22965263

Skauby MH, Øyen O, Hartman A, Leivestad T, Wadström J (2012)
Kidney transplantation with and without simultaneous bilateral native nephrectomy in patients with polycystic kidney disease: a comparative retrospective study
Transplantation, 94 (4), 383-8
DOI 10.1097/TP.0b013e31825812b9, PubMed 22828736

Osthus TB, von der Lippe N, Ribu L, Rustøen T, Leivestad T, Dammen T, Os I (2012)
Health-related quality of life and all-cause mortality in patients with diabetes on dialysis
BMC Nephrol, 13, 78
DOI 10.1186/1471-2369-13-78, PubMed 22863310

Østhus TB, Preljevic VT, Sandvik L, Leivestad T, Nordhus IH, Dammen T, Os I (2012)
Mortality and health-related quality of life in prevalent dialysis patients: Comparison between 12-items and 36-items short-form health survey
Health Qual Life Outcomes, 10, 46
DOI 10.1186/1477-7525-10-46, PubMed 22559816

Stel VS, Kramar R, Leivestad T, Hoitsma AJ, Metcalfe W, Smits JM, Ravani P, Jager KJ (2012)
Time trend in access to the waiting list and renal transplantation: a comparison of four European countries
Nephrol Dial Transplant, 27 (9), 3621-31
DOI 10.1093/ndt/gfs089, PubMed 22555254

Kramer A, Stel VS, Geskus RB, Tizard EJ, Verrina E, Schaefer F, Heaf JG, Kramar R, Krischock L, Leivestad T, Pálsson R, Ravani P, Jager KJ (2011)
The effect of timing of the first kidney transplantation on survival in children initiating renal replacement therapy
Nephrol Dial Transplant, 27 (3), 1256-64
DOI 10.1093/ndt/gfr493, PubMed 21865215

Bjørneklett R, Vikse BE, Bostad L, Leivestad T, Iversen BM (2011)
Long-term risk of ESRD in IgAN; validation of Japanese prognostic model in a Norwegian cohort
Nephrol Dial Transplant, 27 (4), 1485-91
DOI 10.1093/ndt/gfr446, PubMed 21821835

Myhre HA, Haug Dorenberg D, Kristiansen KI, Rollag H, Leivestad T, Asberg A, Hartmann A (2011)
Incidence and outcomes of ganciclovir-resistant cytomegalovirus infections in 1244 kidney transplant recipients
Transplantation, 92 (2), 217-23
DOI 10.1097/TP.0b013e31821fad25, PubMed 21685829

Valderhaug TG, Hjelmesæth J, Hartmann A, Røislien J, Bergrem HA, Leivestad T, Line PD, Jenssen T (2011)
The association of early post-transplant glucose levels with long-term mortality
Diabetologia, 54 (6), 1341-9
DOI 10.1007/s00125-011-2105-9, PubMed 21409415

Norby GE, Leivestad T, Mjøen G, Hartmann A, Midtvedt K, Gran JT, Holdaas H (2011)
Premature cardiovascular disease in patients with systemic lupus erythematosus influences survival after renal transplantation
Arthritis Rheum, 63 (3), 733-7
DOI 10.1002/art.30184, PubMed 21360503

van de Luijtgaarden MW, Noordzij M, Stel VS, Ravani P, Jarraya F, Collart F, Schön S, Leivestad T, Puttinger H, Wanner C, Jager KJ (2011)
Effects of comorbid and demographic factors on dialysis modality choice and related patient survival in Europe
Nephrol Dial Transplant, 26 (9), 2940-7
DOI 10.1093/ndt/gfq845, PubMed 21325351

Heldal K, Hartmann A, Leivestad T, Foss A, Midtvedt K (2011)
Risk variables associated with the outcome of kidney recipients >70 years of age in the new millennium
Nephrol Dial Transplant, 26 (8), 2706-11
DOI 10.1093/ndt/gfq786, PubMed 21285131

Bjørneklett R, Vikse BE, Smerud HK, Bostad L, Leivestad T, Hartmann A, Iversen BM (2011)
Pre-transplant course and risk of kidney transplant failure in IgA nephropathy patients
Clin Transplant, 25 (3), E356-65
DOI 10.1111/j.1399-0012.2011.01424.x, PubMed 21651619

Bleskestad IH, Bergrem H, Leivestad T, Gøransson LG (2011)
Intact parathyroid hormone levels in renal transplant patients with normal transplant function
Clin Transplant, 25 (5), E566-70
DOI 10.1111/j.1399-0012.2011.01515.x, PubMed 21955131

Reisaeter AV, Foss A, Hartmann A, Leivestad T, Midtvedt K (2011)
The kidney transplantation program in Norway since 2000
Clin Transpl, 111-8
PubMed 22755407

Norby GE, Strøm EH, Midtvedt K, Hartmann A, Gilboe IM, Leivestad T, Stenstrøm J, Holdaas H (2010)
Recurrent lupus nephritis after kidney transplantation: a surveillance biopsy study
Ann Rheum Dis, 69 (8), 1484-7
DOI 10.1136/ard.2009.122796, PubMed 20498208

Sandvik MK, Iversen BM, Irgens LM, Skjaerven R, Leivestad T, Søfteland E, Vikse BE (2010)
Are adverse pregnancy outcomes risk factors for development of end-stage renal disease in women with diabetes?
Nephrol Dial Transplant, 25 (11), 3600-7
DOI 10.1093/ndt/gfq275, PubMed 20494895

Vikse BE, Hallan S, Bostad L, Leivestad T, Iversen BM (2010)
Previous preeclampsia and risk for progression of biopsy-verified kidney disease to end-stage renal disease
Nephrol Dial Transplant, 25 (10), 3289-96
DOI 10.1093/ndt/gfq169, PubMed 20348149

Bergrem HA, Valderhaug TG, Hartmann A, Hjelmesaeth J, Leivestad T, Bergrem H, Jenssen T (2010)
Undiagnosed diabetes in kidney transplant candidates: a case-finding strategy
Clin J Am Soc Nephrol, 5 (4), 616-22
DOI 10.2215/CJN.07501009, PubMed 20133490

Gude E, Andreassen AK, Arora S, Gullestad L, Grov I, Hartmann A, Leivestad T, Fiane AE, Geiran OR, Vardal M, Simonsen S (2010)
Acute renal failure early after heart transplantation: risk factors and clinical consequences
Clin Transplant, 24 (6), E207-13
DOI 10.1111/j.1399-0012.2010.01225.x, PubMed 20184627

Heldal K, Hartmann A, Grootendorst DC, de Jager DJ, Leivestad T, Foss A, Midtvedt K (2009)
Benefit of kidney transplantation beyond 70 years of age
Nephrol Dial Transplant, 25 (5), 1680-7
DOI 10.1093/ndt/gfp681, PubMed 20038521

Aasebø W, Midtvedt K, Valderhaug TG, Leivestad T, Hartmann A, Reisaeter AV, Jenssen T, Holdaas H (2009)
Impaired glucose homeostasis in renal transplant recipients receiving basiliximab
Nephrol Dial Transplant, 25 (4), 1289-93
DOI 10.1093/ndt/gfp617, PubMed 19934089

Kramer A, Stel V, Zoccali C, Heaf J, Ansell D, Grönhagen-Riska C, Leivestad T, Simpson K, Pálsson R, Postorino M, Jager K, ERA-EDTA Registry (2009)
An update on renal replacement therapy in Europe: ERA-EDTA Registry data from 1997 to 2006
Nephrol Dial Transplant, 24 (12), 3557-66
DOI 10.1093/ndt/gfp519, PubMed 19820003

Witczak BJ, Leivestad T, Line PD, Holdaas H, Reisaeter AV, Jenssen TG, Midtvedt K, Bitter J, Hartmann A (2009)
Experience from an active preemptive kidney transplantation program--809 cases revisited
Transplantation, 88 (5), 672-7
DOI 10.1097/TP.0b013e3181b27b7e, PubMed 19741464

Gjesdal O, Gude E, Arora S, Leivestad T, Andreassen AK, Gullestad L, Aaberge L, Brunvand H, Edvardsen T, Geiran OR, Simonsen S (2009)
Intra-aortic balloon counterpulsation as a bridge to heart transplantation does not impair long-term survival
Eur J Heart Fail, 11 (7), 709-14
DOI 10.1093/eurjhf/hfp078, PubMed 19515719

Foss A, Heldal K, Scott H, Foss S, Leivestad T, Jørgensen PF, Scholz T, Midtvedt K (2009)
Kidneys from deceased donors more than 75 years perform acceptably after transplantation
Transplantation, 87 (10), 1437-41
DOI 10.1097/TP.0b013e3181a4ebd2, PubMed 19461478

Heldal K, Hartmann A, Leivestad T, Svendsen MV, Foss A, Lien B, Midtvedt K (2009)
Clinical outcomes in elderly kidney transplant recipients are related to acute rejection episodes rather than pretransplant comorbidity
Transplantation, 87 (7), 1045-51
DOI 10.1097/TP.0b013e31819cdddd, PubMed 19352126

Couchoud C, Jager KJ, Tomson C, Cabanne JF, Collart F, Finne P, de Francisco A, Frimat L, Garneata L, Leivestad T, Lemaitre V, Limido A, Ots M, Resic H, Stojceva-Taneva O, Kooman J, QUEST working group on dialysis adequacy (2008)
Assessment of urea removal in haemodialysis and the impact of the European Best Practice Guidelines
Nephrol Dial Transplant, 24 (4), 1267-74
DOI 10.1093/ndt/gfn641, PubMed 19039029

Vikse BE, Irgens LM, Leivestad T, Skjaerven R, Iversen BM (2008)
Preeclampsia and the risk of end-stage renal disease
N Engl J Med, 359 (8), 800-9
DOI 10.1056/NEJMoa0706790, PubMed 18716297

Couchoud C, Kooman J, Finne P, Leivestad T, Stojceva-Taneva O, Ponikvar JB, Collart F, Kramar R, de Francisco A, Jager KJ, QUality European STudies Working Group on Dialysis Adequacy (2008)
From registry data collection to international comparisons: examples of haemodialysis duration and frequency
Nephrol Dial Transplant, 24 (1), 217-24
DOI 10.1093/ndt/gfn442, PubMed 18678560

Tangeraas T, Bjerre A, Lien B, Kyte A, Monn E, Cvancarova M, Leivestad T, Reisaeter AV (2008)
Long-term outcome of pediatric renal transplantation: the Norwegian experience in three eras 1970-2006
Pediatr Transplant, 12 (7), 762-8
DOI 10.1111/j.1399-3046.2007.00896.x, PubMed 18208441

Heldal K, Leivestad T, Hartmann A, Svendsen MV, Lien BH, Midtvedt K (2007)
Kidney transplantation in the elderly--the Norwegian experience
Nephrol Dial Transplant, 23 (3), 1026-31
DOI 10.1093/ndt/gfm719, PubMed 18079146

Vikse BE, Irgens LM, Leivestad T, Hallan S, Iversen BM (2007)
Low birth weight increases risk for end-stage renal disease
J Am Soc Nephrol, 19 (1), 151-7
DOI 10.1681/ASN.2007020252, PubMed 18057216

Valderhaug TG, Hjelmesaeth J, Rollag H, Leivestad T, Røislien J, Jenssen T, Hartmann A (2007)
Reduced incidence of new-onset posttransplantation diabetes mellitus during the last decade
Transplantation, 84 (9), 1125-30
DOI 10.1097/01.tp.0000287191.45032.38, PubMed 17998867

Simonsen S, Andreassen AK, Gullestad L, Leivestad T, Fiane AE, Geiran OR (2007)
[Survival after heart transplantation in Norway]
Tidsskr Nor Laegeforen, 127 (7), 865-8
PubMed 17435806

Øien CM, Reisaeter AV, Leivestad T, Dekker FW, Line PD, Os I (2007)
Living donor kidney transplantation: the effects of donor age and gender on short- and long-term outcomes
Transplantation, 83 (5), 600-6
DOI 10.1097/01.tp.0000255583.34329.dd, PubMed 17353781

Yoshino M, Kuhlmann MK, Kotanko P, Greenwood RN, Pisoni RL, Port FK, Jager KJ, Homel P, Augustijn H, de Charro FT, Collart F, Erek E, Finne P, Garcia-Garcia G, Grönhagen-Riska C, Ioannidis GA, Ivis F, Leivestad T, Løkkegaard H, Lopot F, Jin DC, Kramar R, Nakao T, Nandakumar M, Ramirez S et al. (2006)
International differences in dialysis mortality reflect background general population atherosclerotic cardiovascular mortality
J Am Soc Nephrol, 17 (12), 3510-9
DOI 10.1681/ASN.2006020156, PubMed 17108318

van Manen JG, van Dijk PC, Stel VS, Dekker FW, Clèries M, Conte F, Feest T, Kramar R, Leivestad T, Briggs JD, Stengel B, Jager KJ (2006)
Confounding effect of comorbidity in survival studies in patients on renal replacement therapy
Nephrol Dial Transplant, 22 (1), 187-95
DOI 10.1093/ndt/gfl502, PubMed 16998216

Stewart JH, McCredie MR, Williams SM, Canadian Organ Replacement Register, Fenton SS, Trpeski L, Australia and New Zealand Dialysis and Transplant Registry, McDonald SP, European Renal Association-European Dialysis and Transplant Association Registry, Jager KJ, van Dijk PC, Finnish Registry for Kidney Diseases, Finne P, Swedish Registry for Active Treatment of Uremia, Schon S, Norwegian Renal Registry, Leivestad T, Danish National Registry on Regular Dialysis and Transplantation, Løkkegaard H, Dutch-speaking Belgian Society of Nephrology, Billiouw JM, Austrian Dialysis and Transplant Registry, Kramar R, Basque Renal Patients' Registry, Magaz A et al. (2006)
The enigma of hypertensive ESRD: observations on incidence and trends in 18 European, Canadian, and Asian-Pacific populations, 1998 to 2002
Am J Kidney Dis, 48 (2), 183-91
DOI 10.1053/j.ajkd.2006.04.067, PubMed 16860183

Hjelmesaeth J, Ueland T, Flyvbjerg A, Bollerslev J, Leivestad T, Jenssen T, Hansen TK, Thiel S, Sagedal S, Røislien J, Hartmann A (2006)
Early posttransplant serum osteoprotegerin levels predict long-term (8-year) patient survival and cardiovascular death in renal transplant patients
J Am Soc Nephrol, 17 (6), 1746-54
DOI 10.1681/ASN.2005121368, PubMed 16687626

Hjelmesaeth J, Hartmann A, Leivestad T, Holdaas H, Sagedal S, Olstad M, Jenssen T (2006)
The impact of early-diagnosed new-onset post-transplantation diabetes mellitus on survival and major cardiac events
Kidney Int, 69 (3), 588-95
DOI 10.1038/sj.ki.5000116, PubMed 16395250

Foss A, Tuvin D, Leivestad T, Øyen O, Bentdal Ø (2005)
Should kidneys from older cadaveric donors be age-matched to the recipient?
Transplant Proc, 37 (8), 3280-2
DOI 10.1016/j.transproceed.2005.09.009, PubMed 16298572

Stel VS, van Dijk PC, van Manen JG, Dekker FW, Ansell D, Conte F, Kramar R, Leivestad T, Vela E, Briggs JD, Jager KJ (2005)
Prevalence of co-morbidity in different European RRT populations and its effect on access to renal transplantation
Nephrol Dial Transplant, 20 (12), 2803-11
DOI 10.1093/ndt/gfi099, PubMed 16188902

Øien CM, Reisaeter AV, Leivestad T, Pfeffer P, Fauchald P, Os I (2005)
Gender imbalance among donors in living kidney transplantation: the Norwegian experience
Nephrol Dial Transplant, 20 (4), 783-9
DOI 10.1093/ndt/gfh696, PubMed 15701672

Flesland O, Leivestad T, Solheim BG (2005)
Survival of renal allografts from living donors and the importance of being the mother of the organ donor
Transfus Apher Sci, 32 (1), 13-5
DOI 10.1016/j.transci.2004.06.009, PubMed 15737867

Sagedal S, Hartmann A, Nordal KP, Osnes K, Leivestad T, Foss A, Degré M, Fauchald P, Rollag H (2004)
Impact of early cytomegalovirus infection and disease on long-term recipient and kidney graft survival
Kidney Int, 66 (1), 329-37
DOI 10.1111/j.1523-1755.2004.00735.x, PubMed 15200441

Thorsby E, Pfeffer P, Leivestad T (2004)
Role of HLA molecules in the induction of alloimmune responses: clinical significance in the cyclosporine era
Transplant Proc, 36 (2 Suppl), 16S-21S
DOI 10.1016/j.transproceed.2004.01.058, PubMed 15041301

Albrechtsen D, Leivestad T, Brekke I, Fauchald P, Pfeffer P, Thorsby E, Oslo Kidney Transplant Group (2004)
Experience with cyclosporine in 1519 kidney transplantations from living donors in a national transplant programme, 1983-2002
Transplant Proc, 36 (2 Suppl), 89S-93S
DOI 10.1016/j.transproceed.2004.01.026, PubMed 15041314

Jakobsen A, Holdaas H, Leivestad T (2003)
Ethics and safety of living kidney donation
Transplant Proc, 35 (3), 1177-8
DOI 10.1016/s0041-1345(03)00136-2, PubMed 12947899

Westlie L, Leivestad T, Holdaas H, Lien B, Meyer K, Fauchald P (2003)
[How are living kidney donors doing?]
Tidsskr Nor Laegeforen, 123 (8), 1060-2
PubMed 12760221

Witczak B, Hartmann A, Leivestad T, Øyen O, Svennevig J (2003)
Cardiovascular surgery in renal failure patients with or without subsequent renal transplantation
Transplant Proc, 35 (2), 798-800
DOI 10.1016/s0041-1345(03)00075-7, PubMed 12644143

Westlie L, Leivestad T, Holdaas H, Lien B, Meyer K, Fauchald P (2003)
Report from the Norwegian National Hospitals Living Donor Registry: one-year data, January 1, 2002
Transplant Proc, 35 (2), 777-8
DOI 10.1016/s0041-1345(03)00039-3, PubMed 12644132

Sagedal S, Nordal KP, Hartmann A, Sund S, Scott H, Degré M, Foss A, Leivestad T, Osnes K, Fauchald P, Rollag H (2002)
The impact of cytomegalovirus infection and disease on rejection episodes in renal allograft recipients
Am J Transplant, 2 (9), 850-6
DOI 10.1034/j.1600-6143.2002.20907.x, PubMed 12392291

van Dijk PC, Jager KJ, de Charro F, Collart F, Cornet R, Dekker FW, Grönhagen-Riska C, Kramar R, Leivestad T, Simpson K, Briggs JD, ERA-EDTA registry (2001)
Renal replacement therapy in Europe: the results of a collaborative effort by the ERA-EDTA registry and six national or regional registries
Nephrol Dial Transplant, 16 (6), 1120-9
DOI 10.1093/ndt/16.6.1120, PubMed 11390709

Bergrem H, Leivestad T (2001)
Diabetic nephropathy and end-stage renal failure: the Norwegian story
Adv Ren Replace Ther, 8 (1), 4-12
DOI 10.1053/jarr.2001.21711, PubMed 11172323

Sagedal S, Nordal KP, Hartmann A, Degré M, Holter E, Foss A, Osnes K, Leivestad T, Fauchald P, Rollag H (2000)
A prospective study of the natural course of cytomegalovirus infection and disease in renal allograft recipients
Transplantation, 70 (8), 1166-74
DOI 10.1097/00007890-200010270-00007, PubMed 11063335

Katre S, Leivestad T, Fauchald P (2000)
[Active uremia therapy in autosomal dominant polycystic kidney disease]
Tidsskr Nor Laegeforen, 120 (9), 1015-9
PubMed 10833958

Gjersvik P, Hansen S, Møller B, Leivestad T, Geiran O, Simonsen S, Pfeffer P, Fauchald P (2000)
Are heart transplant recipients more likely to develop skin cancer than kidney transplant recipients?
Transpl Int, 13 Suppl 1, S380-1
DOI 10.1007/s001470050366, PubMed 11112037

Paulsen D, Kløw NE, Rogstad B, Leivestad T, Lien B, Vatne K, Fauchald P (1999)
Preservation of renal function by percutaneous transluminal angioplasty in ischaemic renal disease
Nephrol Dial Transplant, 14 (6), 1454-61
DOI 10.1093/ndt/14.6.1454, PubMed 10383007

Jensen P, Hansen S, Møller B, Leivestad T, Pfeffer P, Geiran O, Fauchald P, Simonsen S (1999)
Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens
J Am Acad Dermatol, 40 (2 Pt 1), 177-86
DOI 10.1016/s0190-9622(99)70185-4, PubMed 10025742

Leivestad T, Reisaeter AV, Brekke IB, Vartdal F, Thorsby E (1999)
The role of HLA matching in renal transplantation: experience from one center
Rev Immunogenet, 1 (3), 343-50
PubMed 11256425

Jensen P, Hansen S, Møller B, Leivestad T, Pfeffer P, Fauchald P (1999)
Are renal transplant recipients on CsA-based immunosuppressive regimens more likely to develop skin cancer than those on azathioprine and prednisolone?
Transplant Proc, 31 (1-2), 1120
DOI 10.1016/s0041-1345(98)01928-9, PubMed 10083500

Reisaeter AV, Leivestad T, Vartdal F, Spurkland A, Fauchald P, Brekke IB, Thorsby E (1998)
A strong impact of matching for a limited number of HLA-DR antigens on graft survival and rejection episodes: a single-center study of first cadaveric kidneys to nonsensitized recipients
Transplantation, 66 (4), 523-8
DOI 10.1097/00007890-199808270-00018, PubMed 9734498

Bergan S, Rugstad HE, Bentdal O, Sødal G, Hartmann A, Leivestad T, Stokke O (1998)
Monitored high-dose azathioprine treatment reduces acute rejection episodes after renal transplantation
Transplantation, 66 (3), 334-9
DOI 10.1097/00007890-199808150-00010, PubMed 9721802

Foss A, Leivestad T, Brekke IB, Fauchald P, Bentdal O, Lien B, Pfeffer P, Sødal G, Albrechtsen D, Søreide O, Flatmark A (1998)
Unrelated living donors in 141 kidney transplantations: a one-center study
Transplantation, 66 (1), 49-52
DOI 10.1097/00007890-199807150-00008, PubMed 9679821

Bentdal OH, Leivestad T, Fauchald P, Albrechtsen D, Pfeffer P, Lien B, Foss A, Oyen O, Hartmann A, Nordal K, Sødal G, Flatmark A, Thorsby E, Brekke IB (1998)
The national kidney transplant program in Norway still results in unchanged waiting lists
Clin Transpl, 221-8
PubMed 10503101

Reisaeter AV, Leivestad T, Fauchald P, Brekke I, Thorsby E (1997)
Influence of matching for HLA-DR in first cadaveric renal transplantation in nonsensitized recipients
Transplant Proc, 29 (7), 3099-100
DOI 10.1016/s0041-1345(97)00798-7, PubMed 9365682

Pfeffer PF, Leivestad T, Albrechtsen D, Fauchald P, Brekke IB (1997)
Anamnestic cancer: how long should the cancer-free interval be before renal transplantation?
Transplant Proc, 29 (7), 3163
DOI 10.1016/s0041-1345(97)00826-9, PubMed 9365710

Hjelmesaeth J, Hartmann A, Kofstad J, Stenstrøm J, Leivestad T, Egeland T, Fauchald P (1997)
Glucose intolerance after renal transplantation depends upon prednisolone dose and recipient age
Transplantation, 64 (7), 979-83
DOI 10.1097/00007890-199710150-00008, PubMed 9381545

Bell H, Thordal C, Raknerud N, Hansen T, Bosnes V, Halvorsen R, Heier HE, Try K, Leivestad T, Thomassen Y (1997)
Prevalence of hemochromatosis among first-time and repeat blood donors in Norway
J Hepatol, 26 (2), 272-9
DOI 10.1016/s0168-8278(97)80041-4, PubMed 9059946

Nordal KP, Hartmann A, Leivestad T, Halvorsen S, Iversen BM, Widerøe TE, Julsrud J (1996)
[Critical shortage of personnel in nephrology. Assessment of causes of the crisis and suggestion for solution]
Tidsskr Nor Laegeforen, 116 (28), 3348-51
PubMed 9011993

Midtvedt K, Tafjord AB, Hartmann A, Eide TC, Holdaas H, Nordal KP, Draganov B, Sødal G, Leivestad T, Fauchald P (1996)
Half dose of OKT3 is efficient in treatment of steroid-resistant renal allograft rejection
Transplantation, 62 (1), 38-42
DOI 10.1097/00007890-199607150-00008, PubMed 8693541

Jakobsen A, Albrechtsen D, Leivestad T (1996)
Renal transplantation--the Norwegian model
Ann Transplant, 1 (3), 32-5
PubMed 9869917

Leivestad T, Foerster A, Simonsen S, Bratlie A, Thorsby E, Geiran O (1996)
HLA-DR matching reduces rejection rate in heart transplantation
Transpl Int, 9 Suppl 1, S230-3
DOI 10.1007/978-3-662-00818-8_59, PubMed 8959835

Reisaeter AV, Leivestad T, Albrechtsen D, Holdaas H, Hartmann A, Sødal G, Flatmark A, Fauchald P (1995)
Pretransplant plasma exchange or immunoadsorption facilitates renal transplantation in immunized patients
Transplantation, 60 (3), 242-8
DOI 10.1097/00007890-199508000-00006, PubMed 7645036

Leivestad T, Spurkland A, Knutsen I, Bratlie A, Vartdal F, Pfeffer P, Sødal G, Fauchald P, Thorsby E (1995)
Genomic HLA-DRB1 matching further improves clinical course after renal transplantation
Transplant Proc, 27 (1), 678-9
PubMed 7879142

Pfeffer PF, Hansen S, Leivestad T, Fauchald P, Brekke IB, Sødal G (1995)
Cancer risk after renal transplantation in the Norwegian transplant program
Transplant Proc, 27 (1), 979-80
PubMed 7879253

Albrechtsen D, Leivestad T, Sødal G, Bentdal O, Berg KJ, Brekke I, Fauchald P, Flatmark A, Jakobsen A, Lien B (1995)
Kidney transplantation in patients older than 70 years of age
Transplant Proc, 27 (1), 986-8
PubMed 7879256

Haugen G, Fauchald P, Sødal G, Leivestad T, Moe N (1994)
Pregnancy outcome in renal allograft recipients in Norway. The importance of immunosuppressive drug regimen and health status before pregnancy
Acta Obstet Gynecol Scand, 73 (7), 541-6
DOI 10.3109/00016349409006270, PubMed 8079604

Bell H, Raknerud N, Try K, Rostad B, Leivestad T (1994)
[Clinical experience with early hemochromatosis]
Tidsskr Nor Laegeforen, 114 (15), 1704-8
PubMed 8079282

Fauchald P, Leivestad T, Rollag H, Albrechtsen D, Sødal G (1994)
Influence of cytomegalovirus antibody status on graft survival in renal transplantation
Transplant Proc, 26 (3), 1725
PubMed 8030103

Leivestad T, Spurkland A, Bratlie A, Pfeffer P, Fauchald P, Sødal G, Thorsby E (1994)
Does genomic HLA-DR matching further enhance the effects of serologic DR matching in clinical renal transplantation?
Transplant Proc, 26 (3), 1748-9
PubMed 8030117

Reisaeter AV, Fauchald P, Leivestad T, Holdaas H, Hartmann A, Pfeffer P, Sødal G (1994)
Plasma exchange in highly sensitized patients as induction therapy after renal transplantation
Transplant Proc, 26 (3), 1758
PubMed 8030121

Leivestad T, Thorsby E (1994)
[The importance of a good HLA match]
Nord Med, 109 (6-7), 188-90, 201
PubMed 8015913

Pfeffer PF, Ohlman S, Jakobsen A, Fauchald P, Leivestad T, Tydén G, Flatmark A (1993)
A Scandinavian two-center study of BMA 031 in steroid-resistant rejection of renal grafts
Transplantation, 56 (2), 304-7
DOI 10.1097/00007890-199308000-00009, PubMed 8102820

Foerster A, Bjørtuft O, Geiran O, Rollag H, Leivestad T, Frøysaker T (1993)
Single lung transplantation. Morphological surveillance by transbronchial biopsy
APMIS, 101 (6), 455-66
DOI 10.1111/j.1699-0463.1993.tb00134.x, PubMed 8395861

Leivestad T, Sødal G, Bratlie A, Albrechtsen D, Fauchald P, Pfeffer P, Vartdal F, Thorsby E (1993)
Role of HLA matching in cadaveric renal transplantation--influence of improved serologic HLA-DR typing
Transplant Proc, 25 (1 Pt 1), 220-1
PubMed 8438277

Solheim BG, Leivestad T, Hanssen LE (1993)
[Changes in consumption of blood--the significance of resource related and economic factors]
Tidsskr Nor Laegeforen, 113 (1), 61-5
PubMed 8424254

Leivestad T, Berger L, Thorsby E (1992)
Beneficial effect of DR matching on cadaveric renal graft survival in Scandiatransplant
Transplant Proc, 24 (6), 2447-8
PubMed 1465824

Hartmann A, Holdaas H, Fauchald P, Nordal KP, Berg KJ, Talseth T, Leivestad T, Brekke IB, Flatmark A (1992)
Fifteen years' experience with renal transplantation in systemic amyloidosis
Transpl Int, 5 (1), 15-8
DOI 10.1007/BF00337183, PubMed 1580980

Spurkland A, Rønningen KS, Leivestad T, Vartdal F, Thorsby E (1992)
HLA-DR-DQ haplotype frequencies in a Norwegian population
Transplant Proc, 24 (1), 298-9
PubMed 1539285

SPURKLAND A, RONNINGEN KS, LEIVESTAD T, VARTDAL F, THORSBY E (1992)
HLA-DR HLA-DQ HAPLOTYPE FREQUENCIES IN A NORWEGIAN POPULATION
Transplant. Proc., 24 (1), 298-299

Gorlén T, Abdelnoor M, Enger E, Halvorsen S, Leivestad T, Malm OJ, Aarseth HP (1992)
Long term morbidity and mortality after kidney transplantation
Scand J Urol Nephrol, 26 (4), 397-401
DOI 10.3109/00365599209181233, PubMed 1292079

Albrechtsen D, Leivestad T, Fauchald P, Flatmark A, Sødal G, Thorsby E (1992)
Results of the National Kidney Transplantation Program in Norway
Clin Transpl, 207-13
PubMed 1306699

Fauchald P, Sødal G, Albrechtsen D, Leivestad T, Berg KJ, Flatmark A (1991)
The use of elderly living donors in renal transplantation
Transpl Int, 4 (1), 51-3
DOI 10.1007/BF00335516, PubMed 2059300

Pfeffer PF, Jakobsen A, Albrechtsen D, Sødal G, Brekke I, Bentdal O, Leivestad T, Fauchald P, Flatmark A (1991)
BMA 031 effectively reverses steroid-resistant rejection in renal transplants
Transplant Proc, 23 (1 Pt 2), 1099-100
PubMed 1989159

Albrechtsen D, Sødal G, Jakobsen A, Brekke I, Bentdal O, Berg KJ, Fauchald P, Pfeffer P, Talseth T, Leivestad T (1990)
Kidney transplantation from a spouse: an alternative to years of dialysis waiting for a graft that may never turn up?
Transplant Proc, 22 (4), 1435
PubMed 2389351

Albrechtsen D, Berg KJ, Brekke I, Fauchald P, Jakobsen A, Sødal G, Talseth T, Leivestad T, Flatmark A (1990)
Renal replacement therapy in the cyclosporine era: results of a national transplantation program
Transplant Proc, 22 (1), 155-6
PubMed 2309295

Albrechtsen D, Flatmark A, Leivestad T, Brynger H, Frødin L, Groth CG, Lundgren G, Persson N (1990)
Efficacy of cyclosporine in renal transplantation from HLA haploidentical living donors: no benefit of transfusion or additional azathioprine
Transplant Proc, 22 (1), 214-5
PubMed 2408207

Jakobsen A, Albrechtsen D, Leivestad T, Sødal G, Talseth T, Flatmark A (1990)
Steroid-resistant rejection: the effect of ATG on renal allograft survival
Transplant Proc, 22 (1), 225
PubMed 2309320

Leivestad T, Albrechtsen D, Bratlie A, Jakobsen A, Pfeffer P, Sødal G, Vartdal F, Flatmark A, Thorsby E (1990)
The role of HLA compatibility in renal transplantation from living donors: an analysis of 379 grafts
Transplant Proc, 22 (1), 153
PubMed 2309293

Fauchald P, Leivestad T, Albrechtsen D, Willassen Y, Jacobsen A, Flatmark A (1990)
Plasma exchange and immunoadsorption prior to renal transplantation in allosensitized patients
Transplant Proc, 22 (1), 149-50
PubMed 2408203

Fauchald P, Joachim Berg K, Brodwall EK, Talseth T, Flatmark A, Leivestad T, Halvorsen S (1990)
[Treatment of chronic kidney failure with dialysis and transplantation. Development, need and organization in Norway]
Tidsskr Nor Laegeforen, 110 (3), 332-4
PubMed 2309173

Halvorsen R, Flesland O, Solheim BG, Borch-Iohnsen B, Leivestad T (1990)
[Iron status in blood donors evaluated by serum ferritin]
Tidsskr Nor Laegeforen, 110 (2), 189-91
PubMed 2300954

Solheim BG, Albrechtsen DH, Evensen SA, Leivestad T (1990)
[Use of leukocyte-filtered, cytomegalovirus-antibody negative and irradiated cellular blood products]
Tidsskr Nor Laegeforen, 110 (1), 42-5
PubMed 2154061

Leivestad T, Halvorsen R, Gaudernack G, Thorsby E (1989)
Ability of pure resting CD8+ human T cells to respond to alloantigen
Scand J Immunol, 29 (5), 543-53
DOI 10.1111/j.1365-3083.1989.tb01157.x, PubMed 2524873

Brinchmann JE, Leivestad T, Vartdal F (1989)
Quantification of lymphocyte subsets based on positive immunomagnetic selection of cells directly from blood
J Immunogenet, 16 (2), 177-83
DOI 10.1111/j.1744-313x.1989.tb00460.x, PubMed 2687388

Nordal KP, Dahl E, Albrechtsen D, Halse J, Leivestad T, Tretlie S, Fauchald P, Flatmark A (1989)
Fewer rejection episodes in kidney graft recipients with aluminum accumulation in bone: an immunosuppressive effect of aluminum toxicity
Transplant Proc, 21 (1 Pt 2), 2046-7
PubMed 2652670

Nordal KP, Dahl E, Albrechtsen D, Halse J, Leivestad T, Tretli S, Flatmark A (1988)
Aluminium accumulation and immunosuppressive effect in recipients of kidney transplants
BMJ, 297 (6663), 1581-2
DOI 10.1136/bmj.297.6663.1581, PubMed 3147082

Leivestad T, Gaudernack G, Halvorsen R, Thorsby E (1988)
A simple and sensitive bioassay for the detection of IL-2 activity
J Immunol Methods, 114 (1-2), 95-9
DOI 10.1016/0022-1759(88)90159-7, PubMed 2972783

Halvorsen R, Leivestad T, Gaudernack G, Thorsby E (1988)
Induction of interleukin-2 production in CD4+ and CD8+ T-cell subsets after activation via CD3 and CD2
Scand J Immunol, 28 (4), 449-55
DOI 10.1111/j.1365-3083.1988.tb01475.x, PubMed 2904172

Fauchald P, Albrechtsen D, Leivestad T, Berg KJ, Talseth T, Flatmark A (1988)
Renal replacement therapy in elderly patients
Transpl Int, 1 (3), 131-4
DOI 10.1007/BF00348834, PubMed 3075472

Bjercke S, Stray-Pedersen S, Leivestad T (1988)
[Immunological aspects of normal pregnancy and recurrent abortions]
Tidsskr Nor Laegeforen, 108 (25), 2031-4
PubMed 3201414

Halvorsen R, Leivestad T, Gaudernack G, Thorsby E (1988)
Accessory cell-dependent T-cell activation via Ti-CD3. Involvement of CD2-LFA-3 interactions
Scand J Immunol, 28 (3), 277-84
DOI 10.1111/j.1365-3083.1988.tb01449.x, PubMed 2461580

Fauchald P, Albrechtsen D, Leivestad T, Pfeffer P, Talseth T, Flatmark A (1988)
Renal replacement therapy in patients over 60 years of age
Transplant Proc, 20 (3), 432-3
PubMed 3289177

Leivestad T, Halvorsen R, Gaudernack G, Thorsby E (1988)
Requirements for phytohaemagglutinin activation of resting pure CD4+ and CD8+ T cells
Scand J Immunol, 27 (5), 565-72
DOI 10.1111/j.1365-3083.1988.tb02384.x, PubMed 3131868

Halvorsen R, Leivestad T, Gaudernack G, Thorsby E (1988)
Role of accessory cells in the activation of pure T cells via the T cell receptor-CD3 complex or with phytohaemagglutinin
Scand J Immunol, 27 (5), 555-63
DOI 10.1111/j.1365-3083.1988.tb02383.x, PubMed 2967540

ALBRECHTSEN D, FAUCHALD P, LEIVESTAD T, TALSETH T, FLATMARK A (1988)
RENAL REPLACEMENT THERAPY IN ELDERLY PATIENTS
Transplant. Proc., 20 (1 1), 367-369

Fauchald P, Leivestad T, Bratlie A, Albrechtsen D, Talseth T, Flatmark A (1987)
Plasma exchange and immunosuppressive therapy before renal transplantation in allosensitized patients
Transplant Proc, 19 (5), 3748-9
PubMed 3313908

Halvorsen R, Gaudernack G, Leivestad T, Vartdal F, Thorsby E (1987)
Activation of resting, pure CD4+, and CD8+ cells via CD3. Requirements for second signals
Scand J Immunol, 26 (2), 197-205
DOI 10.1111/j.1365-3083.1987.tb02252.x, PubMed 2957786

Fauchald P, Leivestad T, Bratlie A, Jakobsen A, Flatmark A (1987)
Plasma exchange and immunosuppressive therapy before renal transplantation in highly sensitized patients
Transplant Proc, 19 (1 Pt 1), 727-8
PubMed 3274854

Leivestad T, Gaudernack G, Ugelstad J, Vartdal F, Thorsby E (1987)
Isolation of pure and functionally active T4 and T8 cells by positive selection with antibody-coated monosized magnetic microspheres
Transplant Proc, 19 (1 Pt 1), 265-7
PubMed 3152700

Solheim BG, Leivestad T (1986)
[Use of blood components, albumin and artificial colloids. The National Hospital 1979-84]
Tidsskr Nor Laegeforen, 106 (23), 1842-4, 1840
PubMed 3764862

LEIVESTAD T, GAUDERNACK G, QVIGSTAD E, UGELSTAD J, THORSBY E (1986)
ISOLATION OF FUNCTIONALLY ACTIVE T-CELL SUBSETS BY MONOCLONAL-ANTIBODIES CONJUGATED TO MONODISPERSE MAGNETIC MICROSPHERES (M-450)
Transplant. Proc., 18 (4), 731-732

Leivestad T, Gaudernack G, Ugelstad J, Thorsby E (1986)
Positive selection of activated T cells of the T8 (CD8) sub-type by immunomagnetic separation
Tissue Antigens, 28 (1), 46-52
DOI 10.1111/j.1399-0039.1986.tb00459.x, PubMed 3018960

Leivestad T, Albrechtsen D, Flatmark A, Thorsby E (1986)
Renal transplants from HLA-haploidentical living-related donors. The influence of donor-specific transfusions and different immunosuppressive regimens
Transplantation, 42 (1), 35-8
DOI 10.1097/00007890-198607000-00007, PubMed 3523880

Gaudernack G, Leivestad T, Ugelstad J, Thorsby E (1986)
Isolation of pure functionally active CD8+ T cells. Positive selection with monoclonal antibodies directly conjugated to monosized magnetic microspheres
J Immunol Methods, 90 (2), 179-87
DOI 10.1016/0022-1759(86)90074-8, PubMed 3088118

LEIVESTAD T, FLATMARK A, THORSBY E (1986)
INFLUENCE OF DONOR-SPECIFIC TRANSFUSION IN RECIPIENTS OF ONE-HLA HAPLOTYPE MISMATCHED KIDNEYS
Transplant. Proc., 18 (1), 88-89

LEIVESTAD T, FLATMARK A, THORSBY E (1985)
TRANSPLANTS OF KIDNEYS FROM ONE-HAPLOTYPE MISMATCHED LIVING RELATED DONORS - EXPERIENCE WITH DONOR-SPECIFIC TRANSFUSIONS AND CYCLOSPORINE
Transplant. Proc., 17 (6), 2679-2680

Leivestad T (1984)
[Production of leukocyte-poor blood. Experience with new disposable filters]
Tidsskr Nor Laegeforen, 104 (31), 2175-8
PubMed 6531771

Leivestad T, Thorsby E (1984)
Effects of HLA-haploidentical blood transfusions on donor-specific immune responsiveness
Transplantation, 37 (2), 175-81
DOI 10.1097/00007890-198402000-00012, PubMed 6198792

Leivestad T, Solheim BG (1983)
[Plasma exchange in immunologic diseases]
Tidsskr Nor Laegeforen, 103 (10), 833-5
PubMed 6879517

Leivestad T, Flatmark A, Hirschberg H, Thorsby E (1982)
Effect of pretransplant donor-specific transfusions in renal transplantation
Transplant Proc, 14 (2), 370-3
PubMed 6214064

Pape J, Jervell J, Anker E, Bergrem H, Dahle K, Leivestad T, vd Lippe A, Myrseth L, Thaulow E, Urving H (1981)
Blood pressure and pulse response to insulin-induced hypoglycemia during non-selective and selective beta-blockade
Acta Med Scand Suppl, 645, 105-8
DOI 10.1111/j.0954-6820.1981.tb02608.x, PubMed 6112844

PAPE J, JERVELL J, ANKER E, BERGREM H, DAHLE K, LEIVESTAD T, MYRSETH L, THAULOW E, URVING H, VANDERLIPPE A (1981)
BLOOD-PRESSURE AND PULSE RESPONSE TO INSULIN-INDUCED HYPOGLYCEMIA DURING NON-SELECTIVE AND SELECTIVE BETA-BLOCKADE
Acta Med. Scand. (645), 105-108

LEIVESTAD T (1954)
[Medical secrecy obligations]
Tidsskr Nor Laegeforen, 74 (10), 369-75
PubMed 13169128

LEIVESTAD T (1954)
[Medical secrecy obligation]
Tidsskr Nor Laegeforen, 74 (9), 341-2; contd
PubMed 13169122

Review articles

Heldal K, Hartmann A, Leivestad T, Lien B, Foss AE, Midtvedt K (2011)
Renal transplantation is also an option for patients over 70
Tidsskr Nor Laegeforen, 131 (20), 2004-7
DOI 10.4045/tidsskr.10.1391, PubMed 22016126

Westlie L, Leivestad T, Holdaas H, Lien B, Hartmann A, Fauchald P (2003)
[Is current practice concerning living donors in kidney transplantations acceptable?]
Tidsskr Nor Laegeforen, 123 (8), 1063-5
PubMed 12760222